Statement Of Financial Position [Abstract]

ABIONYX Pharma - Filing #2813091

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
As at
2021-01-01
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
373,000 EUR
340,000 EUR
Goodwill
5 377 EUR
5 377 EUR
Cash and cash equivalents
4 046 EUR
7 935 EUR
Assets
15 823 EUR
21 832 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
1 418 EUR
1 396 EUR
Share premium
8 599 EUR
179 214 EUR
Equity
7 169 EUR
2 726 EUR
192,000 EUR
8 599 EUR
229,000 EUR
1 418 EUR
126,000 EUR
201,000 EUR
169 829 EUR
10 677 EUR
10,000 EUR
179 214 EUR
87,000 EUR
1 396 EUR
5,000 EUR
39,000 EUR
1 232 EUR
6 629 EUR
164 822 EUR
170 322 EUR
136,000 EUR
Equity and liabilities
15 823 EUR
21 832 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.